A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA places partial hold on late-stage study of Sanofi’s tolebrutinib to treat patients with multiple sclerosis, myasthenia gravis; FDA cites limited number of cases of drug-induced liver injury as cause for hold
Published: July 05, 2022 by SeeNews Pharmaceuticals
McKesson and HCA Healthcare form JV combining McKesson’s US Oncology Research, HCA’s Sarah Cannon Research Institute to expand research, drug development, availability to clinical trials; McKesson also acquires Genospace personal medicine platform
Published: July 01, 2022 by Business Wire
GlycosBio to start recruiting for clinical trial to assess effect modified plant oil has on OTC colloidal oatmeal formulation to treat eczema; US study to be completed by March 2024
Published: June 30, 2022 by Clinical Trials Daily
Children's Hospital Los Angeles collaborates with United Therapeutics on Phase 4 clinical trial to study rapid infusion of Dinutuximab to treat children with high-risk neuroblastoma, a cancer of the nerve cells; study not yet open for recruiting
Published: June 29, 2022 by Contify Life Science News
Bristol Myers Squibb reports mRNA vaccines more effective at developing COVID-19 antibodies in multiple sclerosis patients treated with oral Zeposia ozanimod than non-mRNA vaccines; observation may help in assisting physicians seeking to optimize care
Published: June 29, 2022 by SeeNews Pharmaceuticals

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count